Skip to main content
Displaying 1 - 12 of 24
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
GSK: "Practical tips towards providing holistic care to patients with PBC" (Complete Session)
Webcasts
View
Viral Hepatitis
GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” (Complete Session)
Webcasts
View
Viral Hepatitis
GSK: "Looking To The Future Of Hepatitis B: An Expert Review Of Quantitative Hepatitis B Surface Antigen Assessment” (Complete...
Webcasts
View
Metabolism, Alcohol & Toxicity
Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion and Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
NASH: a growing unmet therapeutic need
Webcasts
View
Metabolism, Alcohol & Toxicity
The underestimated role of thyroid hormone pathway in the pathophysiology of NASH
Webcasts
View
Metabolism, Alcohol & Toxicity
Key take home messages and close
Webcasts
View
Viral Hepatitis
Introduction
Webcasts
View
Immune-Mediated and Cholestatic Diseases
What is the unmet burden of itch from an HCP perspective?
Webcasts
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy